Barbara P Barna

Title: Barbara P. Barna: Innovator in Immunomodulatory Compounds

Introduction

Barbara P. Barna is a notable inventor based in Berea, OH (US). She has made significant contributions to the field of immunology, particularly through her innovative work on compounds that exhibit immunomodulatory activity. Her research has the potential to impact cancer treatment significantly.

Latest Patents

Barbara P. Barna holds a patent for a C-reactive protein fragment with immunomodulatory activity. This patent includes compounds that comprise the optionally modified dodecapeptide fragment A-(SEQ ID No: 1)-B, which corresponds to residues 174 to 185 of C-reactive protein (CRP). The pharmaceutical compositions derived from this research are designed for methods of treating cancer. Notably, liposomal formulations containing the CRP-peptide fragment have shown particular efficacy when administered alongside interleukin-2.

Career Highlights

Throughout her career, Barbara has worked with Syntex (U.S.A.) Inc., where she has been able to apply her expertise in immunology and contribute to groundbreaking research. Her work has not only advanced scientific understanding but also opened new avenues for therapeutic applications.

Collaborations

Barbara has collaborated with esteemed colleagues, including John J. Nestor, Jr. and Teresa H. Ho. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field.

Conclusion

Barbara P. Barna's contributions to immunomodulatory compounds exemplify the impact of innovative research in medicine. Her work continues to pave the way for advancements in cancer treatment and immunology.